Diametric Capital’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $668K | Buy |
678,824
+248,648
| +58% | +$245K | 0.36% | 82 |
|
|
2025
Q1 | $619K | Buy |
430,176
+76,166
| +22% | +$110K | 0.74% | 32 |
|
|
2024
Q4 | $779K | Sell |
354,010
-312,829
| -47% | -$688K | 0.53% | 54 |
|
|
2024
Q3 | $1.1M | Sell |
666,839
-77,003
| -10% | -$127K | 0.54% | 39 |
|
|
2024
Q2 | $1.65M | Buy |
743,842
+667,058
| +869% | +$1.48M | 0.9% | 18 |
|
|
2024
Q1 | $206K | Sell |
76,784
-11,386
| -13% | -$30.5K | 0.11% | 259 |
|
|
2023
Q4 | $264K | Buy |
+88,170
| New | +$264K | 0.16% | 174 |
|
|
2021
Q2 | – | Sell |
-8,902
| Closed | -$250K | – | 153 |
|
|
2021
Q1 | $250K | Buy |
+8,902
| New | +$250K | 0.19% | 106 |
|